While MDA-MB-231 cells as triple negative breast cancer cell line (negative for estrogen, progesterone, and Her2/neu receptors) are long time known for metastatic tumor growth [51] this capability is significantly enhanced and much more accelerated in the MDA-hyb1 and MDA-hyb2 populations. The gene discussed is ERBB2; the disease is metastatic neoplasm.